BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/22/2025 9:26:09 AM | Browse: 180 | Download: 800
 |
Received |
|
2024-06-29 18:23 |
|
Peer-Review Started |
|
2024-06-29 18:23 |
|
First Decision by Editorial Office Director |
|
2024-09-20 02:24 |
|
Return for Revision |
|
2024-09-21 19:03 |
|
Revised |
|
2024-10-19 07:49 |
|
Publication Fee Transferred |
|
2024-12-14 15:14 |
|
Second Decision by Editor |
|
2024-12-10 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-10 03:31 |
|
Articles in Press |
|
2024-12-10 03:31 |
|
Edit the Manuscript by Language Editor |
|
2024-12-24 22:14 |
|
Typeset the Manuscript |
|
2025-01-07 05:51 |
|
Publish the Manuscript Online |
|
2025-01-22 09:26 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Gamma-glutamyl transferase to lymphocyte ratio as a prognostic marker in hepatocellular carcinoma patients undergoing hepatectomy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Peng-Cheng Zhou, Rui Huang, Hai-Tao Wang, Jun Yang, Jian-Dong Peng, Zi-Xuan Fu, Wen-Jun Liao, Hai-Qiang Ma, Lin-Quan Wu and En-Liang Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82060447 and 82260553 |
| Key project of Jiangxi Provincial Natural Science Foundation |
20224ACB206035 |
| Youth Project of Jiangxi Provincial Natural Science Foundation |
20224BAB216057 |
| General project of Jiangxi Provincial Natural Science Foundation |
20232BAB206109 |
| Jiangxi Provincial Natural Science Foundation |
20242BAB26002 |
|
| Corresponding Author |
En-Liang Li, Department of General Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1 Minde Road, Donghu District, Nanchang 330008, Jiangxi Province, China. lienliangyx@163.com |
| Key Words |
Hepatocellular carcinoma; Biomarker; Survival; Time-dependent; Nomogram |
| Core Tip |
This study investigated the gamma-glutamyl transferase to lymphocyte ratio (GLR) as a prognostic biomarker for hepatocellular carcinoma (HCC) after curative liver resection. GLR was shown to predict both short- and long-term survival, with its prognostic value increasing over time. A time-dependent Cox regression model and a prognostic nomogram were developed to enhance clinical decision-making. The findings suggest that GLR can provide valuable insights into patient risk stratification and guide postoperative management in HCC patients. |
| Publish Date |
2025-01-22 09:26 |
| Citation |
Zhou PC, Huang R, Wang HT, Yang J, Peng JD, Fu ZX, Liao WJ, Ma HQ, Wu LQ, Li EL. Gamma-glutamyl transferase to lymphocyte ratio as a prognostic marker in hepatocellular carcinoma patients undergoing hepatectomy. World J Gastrointest Surg 2025; 17(2): 98578 |
| URL |
https://www.wjgnet.com/1948-9366/full/v17/i2/98578.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v17.i2.98578 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
